Home The Word Brain	My Amedeo FAQ Privacy About
	C49 + CC Journal Club For more information, please refer to our special emails from April 13 and May 19.

Hypertension

Free Subscription Articles published in Am Heart J Retrieve available abstracts of 24 articles: HTML format

Single Articles

May 2025
1. TANG Y, Jiang C, Guo J, Li Y, et al
   Study protocol for the healthy family program on population blood pressure: A multicenter, parallel group, cluster randomized, controlled trial in rural China.
   Am Heart J. 2025;283:70-80.
   PubMed     Abstract available
   
   
   April 2025
2. LIYANAGE-DON N, Phillips E, Schwartz JE, Chang MJ, et al
   Implementing Remote Patient Monitoring to Improve Hypertension Control in a Primary Care Network: Rationale and Design of the Monitor-BP Cluster Randomized Trial.
   Am Heart J. 2025 Apr 8:S0002-8703(25)00122-X. doi: 10.1016/j.ahj.2025.
   PubMed     Abstract available
   
   
   
3. ANAND SC, Narowska G, Gangireddy C, Enevoldsen J, et al
   Novel automated electronic medical record-based VEST (virtual echocardiography screening tool) algorithm for pulmonary arterial hypertension.
   Am Heart J. 2025 Apr 5:S0002-8703(25)00102-4. doi: 10.1016/j.ahj.2025.
   PubMed     Abstract available
   
   
   February 2025
4. TIAN Y, Wang X, Hu Z, Yu X, et al
   Design, rationale, and characterization of the Mobile health based OccuPational cardiovascular risk intErventioN study (mHealth-OPEN Study).
   Am Heart J. 2025 Feb 13:S0002-8703(25)00035-3. doi: 10.1016/j.ahj.2025.
   PubMed     Abstract available
   
   
   December 2024
5. SANTORO F, Stiermaier T, Nunez Gil IJ, El-Battrawy I, et al
   Renin angiotensin system inhibitors and outcome in patients with takotsubo syndrome: A propensity score analysis of the GEIST registry.
   Am Heart J. 2024;278:127-138.
   PubMed     Abstract available
   
   
   November 2024
6. SALAM A, Sani MU, Ogah OS, Huffman MD, et al
   deliVERy of optimal blood pressure coNtrol in afrICA (VERONICA)-Nigeria study: Rationale and design of a randomized clinical trial.
   Am Heart J. 2024;277:66-75.
   PubMed     Abstract available
   
   
   September 2024
7. VOLPP KG, Mahraj K, Norton LA, Asch DA, et al
   Design and Rationale of Penn Medicine Healthy Heart, a Randomized Trial of Effectiveness of a Centrally Organized Approach to Blood Pressure and Cholesterol Improvement Among Patients at Elevated Risk of Atherosclerotic Cardiovascular Disease.
   Am Heart J. 2024 Sep 26:S0002-8703(24)00262-X. doi: 10.1016/j.ahj.2024.
   PubMed     Abstract available
   
   
   
8. KERCHEVAL JB, Narcisse DI, Nguyen M, Rao SV, et al
   Characterization of peripheral artery disease and associations with traditional risk factors, mobility, and biomarkers in the project baseline health study.
   Am Heart J. 2024;275:183-190.
   PubMed     Abstract available
   
   
   August 2024
9. KIM CW, Haji M, Lopes VV, Halladay C, et al
   Variations in antihypertensive medication treatment and blood pressure control among Veterans with HIV and existing hypertension.
   Am Heart J. 2024 Aug 29:S0002-8703(24)00204-7. doi: 10.1016/j.ahj.2024.
   PubMed     Abstract available
   
   
   
10. SANNA GD, Erre GL, Cameli M, Guerra F, et al
    Association of sex with in-hospital management and outcomes of patients with heart failure: data from the REAL-HF registry: The impact of sex in patients hospitalized for heart failure.
    Am Heart J. 2024 Aug 27:S0002-8703(24)00221-7. doi: 10.1016/j.ahj.2024.
    PubMed     Abstract available
    
    
    
11. JIANG C, Wang Z, Du X, Wang Y, et al
    Protocol for a randomized controlled trial of intensive blood pressure control on cardiovascular risk reduction in patients with atrial fibrillation: rationale and design of the CRAFT trial.
    Am Heart J. 2024 Aug 23:S0002-8703(24)00203-5. doi: 10.1016/j.ahj.2024.
    PubMed     Abstract available
    
    
    
12. CHEN MT, Vollmer BL, Blyler CA, Cameron NA, et al
    Antihypertensive Medication Prescription Dispensation Among Pregnant Women in the United States: A Cohort Study.
    Am Heart J. 2024 Aug 21:S0002-8703(24)00205-9. doi: 10.1016/j.ahj.2024.
    PubMed     Abstract available
    
    
    July 2024
13. POLSINELLI VB, Koczo A, Johnson AE, Elkayam U, et al
    Race, Hypertensive Disorders of Pregnancy and Outcomes in Peripartum Cardiomyopathy.
    Am Heart J. 2024 Jul 10:S0002-8703(24)00168-6. doi: 10.1016/j.ahj.2024.
    PubMed     Abstract available
    
    
    June 2024
14. METLOCK FE, Kwapong YA, Evans C, Ouyang P, et al
    Design and Rationale of the Social Determinants of the Risk of Hypertension in Women of Reproductive Age (SAFE HEART) Study: An American Heart Association Research Goes Red Initiative.
    Am Heart J. 2024 Jun 9:S0002-8703(24)00138-8. doi: 10.1016/j.ahj.2024.
    PubMed     Abstract available
    
    
    May 2024
15. COMMODORE-MENSAH Y, Chen Y, Ogungbe O, Liu X, et al
    Design and Rationale of the Cardiometabolic Health Program Linked with Community Health Workers and Mobile Health Telemonitoring to Reduce Health DisparitieS (LINKED-HEARTS) Program.
    Am Heart J. 2024 May 15:S0002-8703(24)00123-6. doi: 10.1016/j.ahj.2024.
    PubMed     Abstract available
    
    
    April 2024
16. DAUBERT MA, Stebbins A, Peragallo-Urrutia R, Chiswell K, et al
    Early Postpartum Blood Pressure Screening is Associated with Increased Detection of Cardiovascular Risk Factors in Women with Hypertensive Disorders of Pregnancy.
    Am Heart J. 2024 Apr 4:S0002-8703(24)00076-0. doi: 10.1016/j.ahj.2024.
    PubMed     Abstract available
    
    
    
17. ZHANG H, Huo X, Ren L, Lu J, et al
    Design and rationale of the Comprehensive intelligent Hypertension managEment SyStem (CHESS) evaluation study: a cluster randomized controlled trial for hypertension management in primary care.
    Am Heart J. 2024 Apr 2:S0002-8703(24)00079-6. doi: 10.1016/j.ahj.2024.
    PubMed     Abstract available
    
    
    March 2024
18. MILLER HE, Tierney S, Stefanick ML, Mayo JA, et al
    Vascular health years after a hypertensive disorder of pregnancy: The EPOCH Study.
    Am Heart J. 2024 Mar 12:S0002-8703(24)00055-3. doi: 10.1016/j.ahj.2024.
    PubMed     Abstract available
    
    
    
19. HAMO CE, Schlamp F, Drenkova K, Jindal M, et al
    Burden of cardiometabolic risk factors and vascular health.
    Am Heart J. 2024;269:201-204.
    PubMed     Abstract available
    
    
    February 2024
20. MEHDIPOOR G, Redfors B, Chen S, Gkargkoulas F, et al
    Hypertension, Microvascular Obstruction and Infarct Size in Patients with STEMI Undergoing PCI: Pooled Analysis from 7 Cardiac Magnetic Resonance Imaging Studies.
    Am Heart J. 2024 Feb 29:S0002-8703(24)00050-4. doi: 10.1016/j.ahj.2024.
    PubMed     Abstract available
    
    
    December 2023
21. CHITTURI KR, Haberman D, Wermers JP, Waksman R, et al
    Overview of the 2023 FDA Circulatory System Devices Advisory Panel Meeting on the Symplicity Spyral Renal Denervation System.
    Am Heart J. 2023 Dec 19:S0002-8703(23)00350-2. doi: 10.1016/j.ahj.2023.
    PubMed     Abstract available
    
    
    November 2023
22. KIM M, Choi JH, Kim HK, Kim HL, et al
    Effects of Intensive Blood Pressure Control on Left Ventricular Hypertrophy in Aortic Valve Disease.
    Am Heart J. 2023 Nov 23:S0002-8703(23)00321-6. doi: 10.1016/j.ahj.2023.
    PubMed     Abstract available
    
    
    
23. HAFF N, Sreedhara SK, Wood W, Yom-Tov E, et al
    Testing interventions to reduce clinical inertia in the treatment of hypertension: rationale and design of a pragmatic randomized controlled trial.
    Am Heart J. 2023 Nov 13:S0002-8703(23)00313-7. doi: 10.1016/j.ahj.2023.
    PubMed     Abstract available
    
    
    
24. GNANENTHIRAN SR, Tan I, Atkins ER, Avolio A, et al
    Transforming blood pressure control in primary care through a novel remote decision support strategy based on wearable blood pressure monitoring: The NEXTGEN-BP randomized trial protocol.
    Am Heart J. 2023;265:50-58.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Hypertension is free of charge.